Soft drugs for future treatment of Chronic Obstructive Pulmonary Disease (COPD)

被引：0

作者：

Szelenyi, I. ^{[1
]}

机构：

[1] Univ Erlangen Nurnberg, Inst Expt & Clin Pharmacol & Toxicol, D-91054 Erlangen, Germany

来源：

PHARMAZIE | 2012年 / 67卷 / 05期

关键词：

COLONY-STIMULATING FACTOR; CIGARETTE-SMOKE; RESPONSES;

D O I：

10.1691/ph.2012.1701

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

COPD is a major cause of chronic morbidity and mortality worldwide. Current treatment is aimed at symptomatic relief. In contrast to bronchial asthma, glucocorticoid treatment strategies have proved disappointing. Consequently, there is a need to develop more effective therapeutic strategies to replace present treatment. Advances in understanding the pathogenesis of COPD have the potential for identifying new therapeutic targets. Additionally, forgotten old compounds might undergo a revival by means of novel pharmaceutical technology.

引用

页码：371 / 373

页数：3

共 14 条

[1]

Barnes Peter J, 2004, COPD, V1, P59, DOI 10.1081/COPD-120028701

[2] Chronic obstructive pulmonary disease: molecular and cellular mechanisms [J].

Barnes, PJ ;

Shapiro, SD ;

Pauwels, RA .

EUROPEAN RESPIRATORY JOURNAL, 2003, 22 (04) :672-688

[3] Theophylline restores histone deacetylase activity and steroid responses in COPD macrophages [J].

Cosio, BG ;

Tsaprouni, L ;

Ito, K ;

Jazrawi, E ;

Adcock, IM ;

Barnes, PJ .

JOURNAL OF EXPERIMENTAL MEDICINE, 2004, 200 (05) :689-695

[4] Treatment Effects of Low-Dose Theophylline Combined With an Inhaled Corticosteroid in COPD [J].

Ford, Paul A. ;

Durham, Andrew L. ;

Russell, Richard E. K. ;

Gordon, Fabiana ;

Adcock, Ian M. ;

Barnes, Peter J. .

CHEST, 2010, 137 (06) :1338-1344

[5] Granulocyte-macrophage colony-stimulating factor is a chemoattractant cytokine for human neutrophils: Involvement of the ribosomal p70 S6 kinase signaling pathway [J].

Gomez-Cambronero, J ;

Horn, J ;

Paul, CC ;

Baumann, MA .

JOURNAL OF IMMUNOLOGY, 2003, 171 (12) :6846-6855

[6] Bacterial endotoxin is an active component of cigarette smoke [J].

Hasday, JD ;

Bascom, R ;

Costa, JJ ;

Fitzgerald, T ;

Dubin, W .

CHEST, 1999, 115 (03) :829-835

[7] Is a regenerative approach viable for the treatment of COPD? [J].

Hind, Matthew ;

Maden, Malcolm .

BRITISH JOURNAL OF PHARMACOLOGY, 2011, 163 (01) :106-115

[8] Anti-inflammatory effects and clinical efficacy of theophylline and tulobuterol in mild-to-moderate chronic obstructive pulmonary disease [J].

Kanehara, Masashi ;

Yokoyama, Akihito ;

Tomoda, Yoshitaka ;

Shiota, Naoki ;

Iwamoto, Hiroshi ;

Ishikawa, Nobuhisa ;

Taooka, Yasuyuki ;

Haruta, Yoshinori ;

Hattori, Noboru ;

Kohno, Nobuoki .

PULMONARY PHARMACOLOGY & THERAPEUTICS, 2008, 21 (06) :874-878

[9] Modulation of TNF and GM-CSF release from dispersed human nasal polyp cells and human whole blood by inhibitors of different PDE isoenzymes and glucocorticoids [J].

Marx, D ;

Tassabehji, M ;

Heer, S ;

Hüttenbrink, KB ;

Szelenyi, I .

PULMONARY PHARMACOLOGY & THERAPEUTICS, 2002, 15 (01) :7-15

[10] Lipopolysaccharide-induced lung inflammation is inhibited by neutralization of GM-CSF [J].

Pujic, Ruzica ;

Benediktus, Ewald ;

Plater-Zyberk, Christine ;

Baeuerle, Patrick A. ;

Szelenyi, Stefan ;

Brune, Kay ;

Pahl, Andreas .

EUROPEAN JOURNAL OF PHARMACOLOGY, 2007, 557 (2-3) :230-235

← 1 2 →